核酸内切酶
聚合酶
病毒
化学
病毒学
大流行
甲型流感病毒
酶
生物
生物化学
医学
2019年冠状病毒病(COVID-19)
疾病
传染病(医学专业)
病理
作者
Han Jun Ju,Jian Zhang,Boshi Huang,Dongwei Kang,Bing Huang,Xinyong Liu,Peng Zhan
标识
DOI:10.1021/acs.jmedchem.6b01227
摘要
Influenza virus (IFV) causes periodic global influenza pandemics, resulting in substantial socioeconomic loss and burden on medical facilities. Yearly variation in the effectiveness of vaccines, slow responsiveness to vaccination in cases of pandemic IFV, and emerging resistance to available drugs highlight the need to develop additional small-molecular inhibitors that act on IFV proteins. One promising target is polymerase acidic (PA) endonuclease, which is a bridged dinuclear metalloenzyme that plays a crucial role in initiating IFV replication. During the past decade, intensive efforts have been made to develop small-molecular inhibitors of this endonuclease as candidate agents for treatment of IFV infection. Here, we review the current status of development of PA endonuclease inhibitors and we discuss the applicability of newer medicinal-chemistry strategies for the discovery more potent, selective, and safer inhibitors.
科研通智能强力驱动
Strongly Powered by AbleSci AI